These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2969953)

  • 41. Bromocriptine and lisuride in Parkinson disease.
    Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
    Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pergolide and lisuride in advanced Parkinson's disease.
    Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Goldstein M
    Adv Neurol; 1984; 40():503-7. PubMed ID: 6695627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Five-year follow-up of early lisuride and levodopa combination therapy versus levodopa monotherapy in de novo Parkinson's disease. The French Lisuride Study Group.
    Allain H; Destée A; Petit H; Patay M; Schück S; Bentué-Ferrer D; Le Cavorzin P
    Eur Neurol; 2000; 44(1):22-30. PubMed ID: 10894991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parenteral administration of lisuride in Parkinson's disease.
    Luquin MR; Obeso JA; Martínez-Lage JM; Tresguerres J; Parada J; Nieuweboer B; Dorow R; Horowski R
    Adv Neurol; 1987; 45():561-8. PubMed ID: 3825733
    [No Abstract]   [Full Text] [Related]  

  • 45. TRH test and the continuous dopaminergic stimulation in complicated Parkinson's disease.
    Lestingi L; Bonifati V; Stocchi F; Antonozzi I; Meco G
    Eur Neurol; 1992; 32(2):65-9. PubMed ID: 1563463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lisuride in parkinsonism.
    Gopinathan G; Teräväinen H; Dambrosia JM; Ward CD; Sanes JN; Stuart WK; Evarts EV; Calne DB
    Neurology; 1981 Apr; 31(4):371-6. PubMed ID: 7194429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of lisuride in severe Parkinson's disease.
    Chin D; Yu YL; Huang CY
    Clin Exp Neurol; 1986; 22():63-9. PubMed ID: 3581512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of lisuride in the "on-off" phenomena due to L-dopa].
    Piccinin GL; Piccirilli M; Rizzo PA; Agostini L
    Clin Ter; 1983 Mar; 104(6):469-71. PubMed ID: 6851447
    [No Abstract]   [Full Text] [Related]  

  • 49. Lisuride in Parkinson disease: efficacy of lisuride compared to levodopa.
    Lieberman A; Goldstein M; Neophytides A; Kupersmith M; Leibowitz M; Zasorin N; Walker R; Kleinberg D
    Neurology; 1981 Aug; 31(8):961-5. PubMed ID: 7022259
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of chronic subcutaneous minipump infusion of lisuride upon locomotor activity of rats.
    Wachtel H; Rettig KJ; Löschmann PA
    J Neural Transm Suppl; 1988; 27():177-83. PubMed ID: 3165433
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of lisuride in advanced Parkinson's disease. Potent dopamine and serotonin agonist.
    Lieberman AN; Goldstein M; Neophytides A; Leibowitz M; Gopinathan G; Goodgold A; Pact V; Walker R
    N Y State J Med; 1981 Nov; 81(12):1751-5. PubMed ID: 6949052
    [No Abstract]   [Full Text] [Related]  

  • 52. Subcutaneous infusion of apomorphine and lisuride in the treatment of parkinsonian on-off fluctuations.
    Stibe C; Lees A; Stern G
    Lancet; 1987 Apr; 1(8537):871. PubMed ID: 2882282
    [No Abstract]   [Full Text] [Related]  

  • 53. Lisuride in parkinsonism.
    Parkes JD; Schachter M; Marsden CD; Smith B; Wilson A
    Ann Neurol; 1981 Jan; 9(1):48-52. PubMed ID: 7212665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. At the receiving end of the lisuride pump.
    Todes CJ
    Lancet; 1986 Jul; 2(8497):36-7. PubMed ID: 2873331
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of lisuride and bromocriptine in the treatment of advanced Parkinson's disease.
    Laihinen A; Rinne UK; Suchy I
    Acta Neurol Scand; 1992 Dec; 86(6):593-5. PubMed ID: 1481646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low dose lisuride in advanced Parkinson disease.
    Degl'Innocenti F; Ginanneschi A; Magnolfi S; Catarzi L; Marini P
    Ital J Neurol Sci; 1987 Aug; 8(4):351-5. PubMed ID: 3679785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The dopamine agonist, lisuride, in the therapy of Parkinson disease].
    Madeja UD
    Acta Histochem Suppl; 1992; 42():25-31. PubMed ID: 1584973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lisuride in de novo parkinsonian patients: a four-year follow-up.
    Giovannini P; Scigliano G; Piccolo I; Soliveri P; Suchy I; Caraceni T
    Acta Neurol Scand; 1988 Apr; 77(4):322-7. PubMed ID: 3291546
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subcutaneous apomorphine in parkinsonian on-off oscillations.
    Stibe CM; Lees AJ; Kempster PA; Stern GM
    Lancet; 1988 Feb; 1(8582):403-6. PubMed ID: 2893200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Lisuride in Parkinson disease].
    Leiguarda R; Micheli F; Fernández Pardal M
    Medicina (B Aires); 1985; 45(1):29-34. PubMed ID: 3880105
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.